Trial Profile
A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate when Administered Intra-orally Twice Daily in Patients with Oral Lichen Planus (OLP) using Rivelin-CLO patches
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Clobetasol (Primary)
- Indications Lichen planus
- Focus Proof of concept; Therapeutic Use
- Sponsors AFYX Therapeutics
- 01 Jan 2022 Results published in the Journal of Oral Pathology and Medicine
- 15 Apr 2021 According to an AFYX Therapeutics media release, data from this study was presented at the 2021 American Academy of Oral Medicine (AAOM) Virtual Annual Conference.
- 15 Apr 2021 Results published in the AFYX Therapeutics Media Release